BioSpace News Archive

Biotech Beach

ATEC to Participate in Upcoming January 2023 Investor Conference

Alphatec Holdings, Inc., a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced that management will virtually participate in the 25th Annual Needham Growth Conference with a fireside chat on January 12, 2023, at 3:00p.m. ET.

December 28, 2022
·
1 min read
BioCapital

CEL-SCI Reports Fiscal 2022 Financial Results and Clinical & Corporate Developments

CEL-SCI Corporation reported financial results for the fiscal year ended September 30, 2022, as well as key clinical and corporate developments.

December 28, 2022
·
8 min read
FDA

TG Therapeutics Announces FDA Approval of BRIUMVI™ (ublituximab-xiiy)

TG Therapeutics, Inc. announced the U.S. Food and Drug Administration has approved BRIUMVI™, for the treatment of relapsing forms of multiple sclerosis, to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.

December 28, 2022
·
19 min read
Biotech Beach

Glaukos Announces Participation in the J.P. Morgan Healthcare Conference 2023

Glaukos Corporation announced that its management is scheduled to participate in the 41st Annual J.P Morgan Healthcare Conference on Tuesday, January 10, 2023, at 5:15 p.m. PT in San Francisco, CA.

December 28, 2022
·
1 min read
Cellectis secures a €40 million credit facility from the European Investment Bank to support its Research, Development and Innovation activities

Cellectis, a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced that it has entered into a €40 million credit facility agreement with the European Investment Bank .

December 28, 2022
·
6 min read
NuGen Announces Closing of First Tranche of Private Placement of Units

NuGen Medical Devices Inc. announces that it has closed the first tranche of a non-brokered private placement through the issuance of 2,500,000 units at a price of $0.05 per Unit for gross proceeds of $125,000.

December 28, 2022
·
3 min read